Boundless Bio, Inc.

Nasdaq:BOLD

Pharmaceutical Preparations·SAN DIEGO, CA

Financials

8 shown

Type	Period	Ended	Filed
10-K	FY 2025	12/31/25	3/9/26	→
10-Q	Q3 2025	9/30/25	11/5/25	→
10-Q	Q2 2025	6/30/25	8/5/25	→
10-Q	Q1 2025	3/31/25	5/9/25	→
10-K	FY 2024	12/31/24	3/27/25	→
10-Q	Q3 2024	9/30/24	11/7/24	→
↓

Earnings Releases (8-K)

8 shown

Filed	Period
3/9/26	Q1 FY2026	→
11/5/25	Q4 FY2025	→
8/5/25	Q3 FY2025	→
5/9/25	Q2 FY2025	→
3/27/25	Q1 FY2025	→
11/7/24	Q4 FY2024	→
↓

News (8-K)

7 shown

Filed	Type	Description
6/23/25	Vote	Submission of Matters to a Vote of Security Holders	→
5/23/25	Other	Costs Associated with Exit or Disposal Activities	→
4/1/25	Agreement	Entry into a Material Definitive Agreement	→
12/12/24	Exec Change	Departure or Appointment of Directors or Certain Officers	→
10/15/24	Exec Change	Departure or Appointment of Directors or Certain Officers	→
8/20/24	Exec Change	Departure or Appointment of Directors or Certain Officers	→
↓

Prospectuses & Registrations

6 shown

Filed	Form	Description
4/29/25	ARS	ARS	→
4/1/25	S-3	S-3	→
3/28/24	S-8	S-8	→
3/28/24	424B4	424B4	→
3/21/24	S-1/A	S-1/A	→
3/6/24	S-1	S-1	→

Proxies

2 shown

Filed	Form	Description
4/29/25	DEFA14A	DEFA14A	→
4/29/25	DEF 14A	DEF 14A	→

Filing History(121 filings)

TypeDateAccessionPeriodSize

10-K

Mar 9, 2026

0001193125-26-09754310-K

Dec 31, 2025

24.4 MB

8-K

Mar 9, 2026

0001193125-26-0975358-K

Mar 3, 2026

472.5 KB

SCHEDULE 13G/A

Feb 17, 2026

0001826420-26-000005

—

13.8 KB

SCHEDULE 13G/A

Feb 5, 2026

0000315066-26-000366

—

11.4 KB

Jan 26, 2026

0001193125-26-0216584

Jan 23, 2026

5.2 KB

Jan 26, 2026

0001193125-26-0216574

Jan 23, 2026

5.2 KB

Jan 26, 2026

0001193125-26-0216564

Jan 23, 2026

5.2 KB

Jan 26, 2026

0001193125-26-0216554

Jan 23, 2026

5.2 KB

Jan 26, 2026

0001193125-26-0216544

Jan 23, 2026

5.3 KB

SCHEDULE 13G

Dec 4, 2025

0001104659-25-118546

—

26.7 KB

10-Q

Nov 5, 2025

0001193125-25-26571410-Q

Sep 30, 2025

7.6 MB

8-K

Nov 5, 2025

0001193125-25-2657078-K

Nov 5, 2025

466.8 KB

SCHEDULE 13G/A

Aug 14, 2025

0001415889-25-022005

—

12.4 KB

10-Q

Aug 5, 2025

0000950170-25-10239110-Q

Jun 30, 2025

7.3 MB

8-K

Aug 5, 2025

0000950170-25-1023868-K

Aug 5, 2025

465.4 KB

Jun 23, 2025

0000950170-25-0890894

Jun 23, 2025

5.4 KB

Jun 23, 2025

0000950170-25-0890854

Jun 23, 2025

5.4 KB

Jun 23, 2025

0000950170-25-0890824

Jun 23, 2025

5.3 KB

Jun 23, 2025

0000950170-25-0890774

Jun 23, 2025

5.4 KB

Jun 23, 2025

0000950170-25-0890724

Jun 23, 2025

5.3 KB

Jun 23, 2025

0000950170-25-0890674

Jun 23, 2025

5.3 KB

8-K

Jun 23, 2025

0000950170-25-0890028-K

Jun 23, 2025

171.5 KB

8-K

May 23, 2025

0000950170-25-0769118-K

May 23, 2025

161.9 KB

10-Q

May 9, 2025

0000950170-25-06749610-Q

Mar 31, 2025

7.4 MB

8-K

May 9, 2025

0000950170-25-0674958-K

May 9, 2025

421.1 KB

25 filings shown

Boundless Bio, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Proxies

Filing History(121 filings)

Ownership

Other Filings

Filed	Form	Description
1/26/26	4	4	→
1/26/26	4	4	→
1/26/26	4	4	→
1/26/26	4	4	→
1/26/26	4	4	→
6/23/25	4	4	→
↓

Filed	Form	Description
2/17/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
2/5/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
12/4/25	SCHEDULE 13G	SCHEDULE 13G	→
8/14/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
4/10/25	EFFECT	EFFECT	→
3/27/24	EFFECT	EFFECT	→
↓